Tharimmune (NASDAQ:THAR – Get Free Report) is one of 913 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Tharimmune to similar companies based on the strength of its analyst recommendations, risk, profitability, institutional ownership, dividends, valuation and earnings. Profitability This table compares Tharimmune […]